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Dendritic cells (DCs) and macrophages play impor-
tant roles in maintaining intestinal homeostasis.
However, the molecular mechanisms that regulate
the differentiation and responses of intestinal DCs
and macrophages remain poorly understood. Here,
we have identified microRNA miR-223 as a key
molecule for regulating these processes. Deficiency
of miR-223 led to a significantly decreased number
of intestinal CX3CR1hi macrophages at steady
state. Both intestinal CX3CR1hi macrophages and
CD103+ conventional DCs (cDCs) in miR-223-defi-
cient mice exhibited a strong pro-inflammatory
phenotype. Moreover, miR-223-deficient monocytes
gave rise to more monocyte-derived DCs (moDCs)
and produced more pro-inflammatory cytokines
upon stimulation. Using a mouse model of colitis,
we demonstrated that the miR-223 deficiency re-
sulted in more severe colitis. Target gene analysis
further identified that the effects of miR-223 on DCs
and macrophages were mediated by directly target-
ing C/EBPb. Taken together, our study identifies a
role for miR-223 as a critical regulator of intestinal
homeostasis.INTRODUCTION
The small intestinal mucosa represents the body’s largest
surface area to the external environment (Gill et al., 2010). The in-
testinal mucosal immune system plays an essential role in pro-
tecting against infection while avoiding the development of
destructive inflammatory responses to the commensal micro-
biota. Intestinal dendritic cell (DC) and macrophage subsets
are believed to play crucial roles in maintaining intestinal homeo-
stasis in the steady state and in driving protective immune
responses in the setting of intestinal infection (Coombes and
Powrie, 2008). Failure to maintain the balance between intes-
tinal immune tolerance and immune responses to pathogens in
genetically predisposed hosts may contribute to chronic inflam-Cell Repmatory bowel diseases (IBD), including Crohn’s disease (CD)
and ulcerative colitis (UC) (Neurath, 2014).
Both DCs and macrophages in the intestinal mucosa co-
express CD11c and class II major histocompatibility complex
(MHC II). DCs also express CD103 (integrin aE), while macro-
phages are CD103– and express high levels of the chemokine
CX3C receptor (CX3CR)1, as well as F4/80 and CD64 (Mildner
and Jung, 2014). The CX3CR1hi macrophages are present
throughout the intestine, and their abundance increases
progressively toward the colon. The intestinal macrophages
possess high phagocytic activity, protect the host from patho-
genic microbial infection, and limit colitogenic Th17 responses
(Mildner and Jung, 2014; Medina-Contreras et al., 2011). The
CD103+ DCs are present in both the intestinal mucosa and the
draining lymph nodes (LNs). They have the ability to prime naive
T cells efficiently, induce the expression of gut-homing mole-
cules on T cells, and prompt the differentiation of forkhead box
(Fox)p3+ regulatory T cells in steady state. Intestinal CD103+
DCs are not a homogeneous population and consist of two
distinct DC subsets, based on the expression of CD11b. The
majority of CD103+ DCs in the small intestinal lamina propria
express CD11b, whereas a minor population is CD11b (Far-
ache et al., 2013; Mortha et al., 2014).
CD103+ DCs are originated from common DC progenitors
(CDPs) andpre-DCs under the control of Flt3. TheCX3CR1himac-
rophages are exclusively originated fromLy6C+monocytes under
the control of macrophage-colony-stimulating factor receptor
(M-CSFR) (Bogunovic et al., 2009). Although most tissue macro-
phages are established pre-birth and subsequently maintain
themselves through longevity and limited self-renewal, recent
studieshave revealed that intestinalmacrophagesare replenished
byperipheral bloodmonocytesconstantly (Hashimotoetal., 2013;
Yonaet al., 2013). TheseLy6C+bloodmonocytes differentiate into
tolerant CX3CR1hi macrophages in healthy intestine. However,
during colitis, they massively invade the colon and differentiate
into pro-inflammatory CD103CX3CR1intCD11b+ DCs, which
produce high levels of IL-12, IL-23, and TNF-a; migrate to draining
LNs; and prime T cell differentiation toward the Th1 or Th17 line-
ages (Zigmond et al., 2012; Rivollier et al., 2012). Considering
the complexity of diversity and function of DCs andmacrophages
in intestine, the molecular mechanism governing local differentia-
tion and conditioning of DCs andmacrophages has emerged as a
key element for the maintenance of gut homeostasis.orts 13, 1149–1160, November 10, 2015 ª2015 The Authors 1149
Figure 1. The Expression of miR-223 Decreased in Macrophages
and DCs of Small Intestine during DSS-Induced Colitis
(A) TaqMan mouse miRNA expression analysis of immune-related miRNA in
DCs (R1) andmacrophages (R2) before and after DSS-induced colitis. Data are
presented on a heatmap showing log2-transformed relative expression (DCt)
standardized to an endogenous noncoding small RNA control sno202 and
normalized using median normalization.
(B) Mice were provided with 3% (w/v) DSS dissolved in the drinking water
for 6 days. Dynamic changes of miR-223 expression in macrophages (R2),
CD103+CD11b DCs (R3), CD103+CD11b+ DCs (R4), and CD103CD11b+
DCs (R5) sorted from the colon of DSS-treated mice are shown. Results
represent mean (±SEM) of three independent experiments with pooled cells
from eight mice per experiment (*p < 0.05 and **p < 0.01).The CCAAT/enhancer-binding protein (C/EBP) family contain-
ing six members (C/EBPa, b, g, d, ε, and z) belongs to the basic
region-leucine zipper (bZIP) class of basic domain transcription
factors (Roos and Nord, 2012). Among them, C/EBPb has
been shown to be critical for normal macrophage function (Ruf-
fell et al., 2009) and C/EBPb targets several genes, including
those coding for cytokines such as IL-6 (Natsuka et al., 1992),
IL-4 (Davydov et al., 1995), IL-5 (van Dijk et al., 1999), and
TNF-a (Yan et al., 2012). The absence of C/EBPb resulted in an
impaired induction of pro-inflammatory cytokines stimulated
by TLR ligands (Screpanti et al., 1995; Gorgoni et al., 2002;
Yan et al., 2012). The transcriptional, isoform, and activity levels
of C/EBPb have been reported to be modulated by inflammatory
stimuli, such as cytokines (i.e., TNF-a, IL-1, and IL-6) as well as1150 Cell Reports 13, 1149–1160, November 10, 2015 ª2015 The Aulipopolysaccharide (LPS), indicating a role for C/EBPb in the
acute-phase inflammatory response (Roos and Nord, 2012;
Poli, 1998). In addition, C/EBPb has been shown to be required
for emergency granulopoiesis, facilitating both differentiation
and proliferation of granulocyte precursors (Hirai et al., 2006).
MicroRNAs (miRNAs) are small RNA molecules that regu-
late gene expression at the post-transcriptional level. Different
miRNAs have been reported to play important roles in regulating
the development or responses of the immune system (O’Connell
et al., 2012). Among them,miR-223 was demonstrated to specif-
ically express highly in the myeloid cells and regulate the prolif-
eration and function of granulocyte (Chen et al., 2004; Johnnidis
et al., 2008). In this study, we investigated the roles of miR-223 in
regulating the differentiation and function of DCs and macro-
phages in lymphoid and non-lymphoid tissues by analyzing the
miR-223-deficient mouse model, the miR-223/Y mice. Our re-
sults demonstrated that miR-223 deficiency led to an impaired
differentiation of the intestinal CX3CR1hi macrophages in steady
state, and both intestinal CX3CR1hi macrophages and CD103+
conventional DC (cDC) in miR-223/Y mice exhibited a strong
pro-inflammatory phenotype, which resulted in more severe
colitis induced by dextran sodium sulfate (DSS). Target gene
analysis further demonstrated that C/EBPb was a direct target
of miR-223, and knockdown of C/EBPb alleviated the effects
of miR-223 deficiency. Our results, therefore, identified miR-
223 as a crucial regulator for the differentiation and function of
intestinal macrophages and DCs, which play an important role
in the maintenance of intestinal homeostasis.
RESULTS
The Expression of miR-223 Decreased Significantly in
Intestinal DCs and Macrophages upon Induction of
Colitis
Our preliminary studies on the expression profiles of miRNAs by
the antigen-presenting cells (APCs) demonstrated that different
DC and macrophage populations differentially expressed some
immune-related miRNAs. Among 29 selected miRNAs, miR-
223 was one of the most abundantly expressed miRNAs in
APCs, including DCs and macrophages in mouse intestine (Fig-
ure 1A), suggesting miR-223 as a myeloid-enriched miRNA,
which is consistent with what had been reported previously
(Chen et al., 2004). More interestingly, we found that, during
the course of colitis induction, the expression levels of miR-
223markedly decreased in both colonic DC subsets andmacro-
phages (Figure 1B). Therefore, we hypothesized that miR-223
might have a role in regulating the differentiation and/or function
of intestinal DCs and macrophages.
Cell-Intrinsic Defect of CX3CR1hi Macrophages in miR-
223-Deficient Mice
To investigate the function ofmiR-223 inDCandmacrophagedif-
ferentiation,we first examined the composition of DCandmacro-
phage subsets in the spleen (lymphoid tissue) and small intestine
(non-lymphoid tissue) of miR-223/YCx3cr1gfp/+ (miR-223-defi-
cient) and miR-223+/YCx3cr1gfp/+ (miR-223 wild-type [WT])
mice. Phenotypic analysis revealed that there were no differ-
ences in the frequency and cell number of DC and macrophagethors
Figure 2. Reduction of CX3CR1hi Macro-
phages in miR-223-Deficient Mice
(A and B) Representative flow cytometry analyses
of CX3CR1hi macrophages (A) and CD103+ DC
subsets (B) isolated from steady-state small
intestine ofmiR-223+/YCX3CR1gfp/+ ormiR-223/Y
CX3CR1gfp/+ mice are shown.
(C and D) The percentages (C) and total numbers
(D) of macrophages and DC subsets in small in-
testine of miR-223+/YCX3CR1gfp/+ or miR-223/Y
CX3CR1gfp/+ mice are presented (n = 9).
(E and F) The percentages (E) and total numbers (F)
of CX3CR1hi macrophages in small intestine of BM
chimeric mice also are presented (n = 9). Error bars
represent SEM (**p < 0.01 and ***p < 0.001).populations in the spleenofWTandmiR-223-deficientmice (data
not shown). However, significant reductions in the frequency and
cell number of the CX3CR1hiCD103CD11b+ macrophage
population were observed in miR-223/YCx3cr1gfp/+ mice when
compared with those of miR-223+/YCx3cr1gfp/+ mice (Figures
2A, 2C, and 2D). These reductions were specific for intestinal
CX3CR1hi macrophages, as no significant differences in the cell
numbers of CD11c+CD103+CD11b, CD11c+CD103+CD11b+,
and CD11c+CD103CD11b+ DCs were detected between
miR-223-deficient and control mice (Figures 2B, 2C, and 2D).
Similarly, the number of CX3CR1hi macrophages in the colon of
miR-223/Y mice also decreased (Figures S1A and S1B).
To determine whether the reduction in cell numbers
of CX3CR1hi macrophages was a cell-intrinsic defect or aCell Reports 13, 1149–1160, Nocell-extrinsic requirement for miR-223,
we generated bone marrow (BM)
chimeric mice in which CD45.1+miR-
223+/YCx3cr1gfp/+ or CD45.1+miR-223/Y
Cx3cr1gfp/+ BM cells were transferred
together with an equal number of
CD45.2+ BM cells into lethally irradiated
CD45.2+ recipients, respectively. Then,
3 weeks after transplantation, we
observed significant reductions in the
frequency and cell numbers of intes-
tinal CX3CR1hi macrophages derived
from BM cells of CD45.1+miR-223/Y
Cx3cr1gfp/+ mice (Figures 2E and 2F),
indicating a cell-intrinsic defect in the dif-
ferentiation of CX3CR1hi intestinal macro-
phages in miR-223-deficient mice.
Unlike macrophages in most tissues
that are yolk-sac-derived, CX3CR1hi
macrophages are replenished by pe-
ripheral Ly6C+ monocytes continuously
(Yona et al., 2013). BM granulocyte and
monocyte precursors (GMPs) can give
rise to Ly6C+ monocytes (Friedman,
2007). We therefore examined GMPs as
well as monocytes in the BM and pe-
ripheral blood to evaluate whether the
reduction of CX3CR1hi macrophages inmiR-223/Y mice was a reflection of a general defect in mono-
cyte/macrophage differentiation or a developmental blockage
at the precursor stage. Our results demonstrated that both the
frequency and total cell number of GMPs were increased in
miR-223/Y mice (Figures 3A and 3B), whereas the frequency of
Ly6C+ monocytes in the BM (Figures 3C and 3D), peripheral
blood (Figures 3E and 3F), and colon (Figure S1C) all decreased
significantly. In addition, an increase in the number of granulocyte
progeny of GMPs was observed in the BM of miR-223-deficient
mice (data not shown), suggesting that the reduction of Ly6C+
monocytes was more likely due to the defect in their differentia-
tion or a developmental bias toward granulocytes from GMPs.
Meanwhile, the expression level of CCR2, an important re-
ceptor for monocyte migration, did not change in miR-223/Yvember 10, 2015 ª2015 The Authors 1151
Figure 3. Decreased Number of Ly6C+
Monocytes in miR-223/Y Mice
(A) Flow cytometry analysis for the presence of
GMP (LinCD117+Sca-1CD34+CD16/32hi), CMP
(LinCD117+Sca-1CD34+CD16/32int), and MEP
(LinCD117+Sca-1CD34CD16/32lo) in BM of
miR-223+/Y and miR-223/Y mice is shown.
(B) The percentages and cell numbers of GMP,
CMP, and MEP in the BM of miR-223+/Y and miR-
223/Ymice are shown (n = 9). Error bars represent
SEM (*p < 0.05 and **p < 0.01).
(C) Flow cytometry analysis of Ly6C+ mono-
cytes (CD115+CD11b+Ly6C+Ly6G) in BM ofmiR-
223+/Y and miR-223/Y mice is shown.
(D) Percentages and total numbers of Ly6C+
monocytes in BM are shown (n = 9).
(E) Flow cytometry analysis for the presence
of Ly6C+ monocytes in peripheral blood of miR-
223+/Y and miR-223/Y mice. Data are represen-
tative of three independent experiments.
(F) The percentages of Ly6C+ monocytes in pe-
ripheral blood from nine individual mice. Error bars
represent SEM (**p < 0.01 and ***p < 0.001).monocytes (Figure S2A). Furthermore, the reduction of
CX3CR1hi macrophages was not likely the result of a defective
differentiation of monocytes to macrophages, since, in the pres-
ence of M-CSF, the Ly6C+ monocytes from BM of miR-223+/Y
Cx3cr1gfp/+ and miR-223/YCx3cr1gfp/+ mice yielded compara-
ble numbers of F4/80+MHCII+ macrophages displaying high
CX3CR1-GFP expression (Figures S2B and S2C). To further
study if the defect of Ly6C+ monocytes in miR-223-deficient
mice was cell intrinsic, we generated BM chimeric mice in which
CD45.1+miR-223+/Y orCD45.1+miR-223/Y BM cells were trans-
planted together with an equal number of CD45.2 normal BM
cells into lethally irradiated CD45.2+ recipients, respectively.
Then, 4 weeks after transplantation, similar reductions in the fre-1152 Cell Reports 13, 1149–1160, November 10, 2015 ª2015 The Authorsquency and number of the Ly6C+ mono-
cytes in the BM of CD45.1+miR-223/Y
chimeric mice were observed (Figure S3).
Taken together, our results demonstrated
that the reduction in the number of
CX3CR1hi intestinal macrophages was
mainly attributed to the defective differen-
tiation of monocyte from GMP.
miR-223-Deficient Intestinal
Macrophages and DCs Exhibited a
Strong Pro-inflammatory
Phenotype
To test if miR-223 also could affect the
functions of both intestinal macrophages
and DCs, we determined the capacities
of cytokine production by the resident
CX3CR1hi macrophages and CD103+
DC subsets freshly isolated from the small
intestine of the miR-223/YCx3cr1gfp/+
mice and themiR-223+/YCx3cr1gfp/+ con-
trol mice. The qRT-PCR analyses re-vealed that the mRNA levels of pro-inflammatory cytokines,
such as TNF-a and IL-1bmRNA in macrophage and DC subsets
and IL-23amRNA in CD103+CD11b+ DCs (Figures 4A–4D), were
all upregulated in miR-223-deficient mice and exhibited a stron-
ger pro-inflammatory cytokine signature than that of control
mice. In contrast, the expression of anti-inflammatory cytokine
TGF-b in CD103+CD11b+ DCs and macrophages from miR-
223/Y mice was lower than that of control mice (Figures 4A
and 4D). In addition, when co-cultured with CD25 T cells, the
CX3CR1hi macrophages from miR-223/YCx3cr1gfp/+ mice
induced less T-regulatory (Treg) cells (Figure S4A). In line with
the functional change of the miR-223-deficient CX3CR1hi mac-
rophages, we observed a trend of reduction of Treg cells in the
Figure 4. miR-223-Deficient Macrophages
and DCs Exhibited a Strong Pro-inflamma-
tory Phenotype
(A–D) The qRT-PCR analyses of cytokine expres-
sion by CD103+CD11b+ DCs (A), CD103+CD11b
DCs (B), CD103CD11b+ DCs (C), and CX3CR1hi
macrophages (D) isolated from the colon of miR-
223+/YCX3CR1gfp/+ or miR-223/YCX3CR1gfp/+
mice are shown (n = 6).
(E) Flow cytometry analysis of BM-derived GM-
DCs of miR-223+/YCX3CR1gfp/+ or miR-223/Y
CX3CR1gfp/+ mice after 7 days in culture with GM-
CSF and IL-4 is shown.
(F) The percentages and cell numbers of GM-DCs
were calculated.
(G) Flow cytometry analysis of moDCs derived
from Ly6C+ monocytes ofmiR-223+/YCX3CR1gfp/+
or miR-223/YCX3CR1gfp/+ mice after 7 days in
culture with GM-CSF and IL-4 is shown.
(H) The percentages and cell numbers of moDCs
generated as in (G) are shown.
(I) The moDCs were stimulated with 1 mg/ml LPS
for 24 hr. The production of IL-23, IL-12p70,
TNF-a, and IL-6 were measured by ELISA. All re-
sults represent the mean (±SEM) of three inde-
pendent experiments (**p < 0.01 and ***p < 0.001).intestine of miR-223/YCx3cr1gfp/+ mice, though the difference
was not statistically significant (Figure S4B).
As it has been shown that inflammation switches the differen-
tiation program of Ly6C+ monocytes from anti-inflammatory
CX3CR1hi macrophages to inflammatory DCs in the colon (Zig-
mond et al., 2012; Rivollier et al., 2012), we also investigated
the function of miR-223 in the differentiation of inflammatory
DCs. The BM cells from miR-223+/Y and miR-223/Y mice were
cultured with GM-CSF and IL-4 to induce DC differentiation
in vitro. A 2-fold increase in the numbers of GM-CSF-induced
DCs (GM-DCs) from the BM cells ofmiR-223/Ymice compared
with miR-223+/Y mice was observed (Figures 4E and 4F). To
further test if the differentiation of DCs from monocytes also
was affected inmiR-223/Y mice, we isolated Ly6C+ monocytes
from the BM of miR-223+/Y and miR-223/Y mice and culturedCell Reports 13, 1149–1160, Nothem with GM-CSF and IL-4. Similarly,
miR-223-deficient monocytes gave rise
to considerably more monocyte-derived
DCs (moDCs) in the cultures than in con-
trols (Figures 4G and 4H), suggesting an
important role of miR-223 in controlling
the differentiation of inflammatory DCs.
These CD11c+ moDCs expressed an in-
termediate level of CX3CR1-GFP when
compared with in vitro M-CSF-induced
macrophages, which expressed high
levels of CX3CR1-GFP (Figures S2D).
Furthermore, when stimulated with LPS,
the miR-223/Y moDCs produced more
pro-inflammatory cytokines, including IL-
23, IL-12p70, TNF-a, and IL-6 (Figure 4I).
Taken together, the miR-223-deficient
CX3CR1hi macrophages, CD103+ DCs,and moDCs, exhibited a strong pro-inflammatory phenotype,
suggesting an important role of miR-223 in restricting the differ-
entiation and functions of the intestinal DCs and macrophages
during inflammatory responses.
miR-223 Deficiency Resulted in More Severe Colitis
To further determine the consequences of the altered differenti-
ation and functions of intestinal macrophages andDCs observed
in miR-223-deficient mice, we tested the effects of miR-223 defi-
ciency on the development of colitis using the DSS-induced
colitis mouse model (Wirtz et al., 2007). The miR-223/Y mice
or miR-223+/Y littermate controls were challenged with 3%
DSS in drinkingwater for 5 days. Then, 5 days later, the intestines
of the treatedmice were examined for the development of colitis.
The miR-223/Y mice exhibited more severe signs of intestinalvember 10, 2015 ª2015 The Authors 1153
Figure 5. miR-223 Deficiency Resulted in
More Severe Colitis
(A) The miR-223+/Y mice and miR-223/Y litter-
mates received 3% DSS in drinking water for
5 days. The DAI score of colitis in DSS-treated
miR-223+/Y and miR-223/Y mice was measured
by stool consistency, presence of fecal blood, and
weight loss.
(B) The weight loss after DSS treatment was
measured. Data of (A) and (B) represent the mean
of four to five mice at each time point from three
independent experiments.
(C) The colon length is shown.
(D) Representative histological analysis of
the rectum of DSS-treated miR-223+/Y and miR-
223/Y mice is shown.
(E) Graphical summary of IL-1b, TNF-a, IL-6, and
IL-23 concentrations in the culture supernatants of
colon explants before and after DSS treatment
determined by ELISA (n = 4–8). Data are repre-
sentative of three independent experiments and
each contained four to eight mice. Error bars
represent SEM (*p < 0.05, **p < 0.01, and ***p <
0.001).disease than the control mice, as defined by an increased overall
disease activity index (DAI), a measure of weight loss, fecal
blood, and soft stool/diarrhea (Figures 5A and 5B). Histological
analysis of the intestine showed more severe tissue damage,
shorter colon length, and greater infiltration of inflammatory cells
in the colon of DSS-treated miR-223/Y mice (Figures 5C and
5D). Cytokine analysis of the supernatants from colon explant
cultures also revealed a significant increase in the production
of IL-1b, TNF-a, IL-6, and IL-23 by the colon tissue of miR-
223/Y mice (Figure 5E).
To confirm that the effects of miR-223 deficiency on the devel-
opment of colitis were mainly attributable to the BM-derived
cells, we constructed the BM chimeric mice and then induced
colitis. The results demonstrated that chimeric mice derived
from the miR-223/Y BM also developed more severe colitis1154 Cell Reports 13, 1149–1160, November 10, 2015 ª2015 The Authors(Figure S5). To further evaluate the contri-
bution of miR-223-deficient moDCs that
mimic inflammatory DCs to the develop-
ment of colitis, we used the T cell trans-
fer-induced colitis mouse model and
transferred moDCs derived from miR-
223/Y or control mice, respectively.
Compared with control moDCs, transfer
of miR-223/Y moDCs resulted in a more
severe colitis (Figure S6).
C/EBPbWas Identified as a Direct
Target of miR-223
To gain an insight into the mechanisms of
miR-223 in regulating the functions of
the intestinal macrophages and DCs, we
conducted computational analysis of pu-
tative miR-223 targets (Friedman et al.,
2009; Kr€uger and Rehmsmeier, 2006).Among the predicted targets, C/EBPb was the only one with
known roles both in hematopoietic differentiation and inflamma-
tory responses (Hirai et al., 2006; Yan et al., 2012). In this study,
we found that C/EBPb expression could be induced during both
GM-DC differentiation and TLR-induced DC activation (Fig-
ure 6A). In the meantime, miR-223 was found decreased in
both processes (Figures 6B and 6C), indicating a reverse corre-
lation between miR-223 and C/EBPb.
Sequence alignment of miR-223 with C/EBPb mRNA pre-
dicted that C/EBPb was likely a direct target of miR-223, and
the binding site was conserved in human and mouse (Figure 6D).
Earlier studies also demonstrated that miR-223 downregulated
C/EBPb expression in K562 and HEK293T cell lines (Sun et al.,
2010b). To confirm that miR-223 also regulates C/EBPb expres-
sion in DCs and macrophages in this study, we compared the
Figure 6. miR-223 Regulates the Function
of Macrophages and DCs by Targeting
C/EBPb
(A) Western blot analysis of protein levels of
C/EBPb. GM-DCs (left) were generated by
culturing BM cells with GM-CSF and IL-4 for 4 or
7 days. The moDCs (right) were stimulated with
LPS for various time points. Proteins were ex-
tracted at indicated time points and subjected to
western blot analysis for C/EBPb expression. The
intensities of each band relative to the 0 time point
were measured by ImageJ software.
(B) The expression levels of miR-223 during GM-
DC differentiation are shown.
(C) The expression levels of miR-223 during moDC
activation. The intensities were normalized to the
respective 0 time point.
(D) Predicted binding site of miR-223 in the 30UTR
of C/EBPb and the mutation of binding site are
shown.
(E and F) The protein (E) and mRNA levels (F) of
C/EBPb in GM-DCs and CX3CR1hi macrophages
are shown.
(G) The mean fluorescence intensities of DsRed in
the transfected GM-DCs with plasmid containing
WTC/EBPb 30UTR fragment or plasmid containing
corresponding mutant C/EBPb 30UTR fragment.
Data are representative of three independent ex-
periments. Error bars represent SEM (**p < 0.01).mRNA and protein levels of C/EBPb in CX3CR1hi macrophages
in small intestine and GM-DCs between miR-223+/Y and miR-
223/Y mice. Higher C/EBPb protein levels were found in both
cell types from the miR-223/Y mice (Figure 6E). However, real-
time RT-PCR revealed that there was no significant difference
inC/EBPbmRNA levels in these cells from themiR-223-deficient
mice and the control mice (Figure 6F), indicating that miR-223
inhibited C/EBPb expression in a post-transcriptional manner.
To confirm that miR-223 interacted with the 30UTR of C/EBPb
in this study, a fragment of C/EBPb 30UTR that contained the
miR-223-binding site was cloned downstream of the DsRed
fluorescent protein gene and transfected into miR-223+/Y or
miR-223/Y GM-DCs. A higher level of fluorescence expression
in miR-223-deficient GM-DCs was observed, indicating that
the expression of C/EBPb could not be downregulated in the
absence of miR-223 binding. Furthermore, the mutation of the
seed sequence for miR-223 at 30UTR of C/EBPb failed to down-Cell Reports 13, 1149–1160, Noregulate the fluorescence expression by
both miR-223/Y and control GM-DCs
(Figure 6G).
miR-223 Regulated the Pro-
inflammatory Responses by
Targeting C/EBPb
As shown above that miR-223 directly
regulated C/EBPb expression, it therefore
was crucial to confirm that the higher pro-
tein level of C/EBPb mediated the miR-
223/Y phenotype. To this end, the BM
cells of miR-223+/Y or miR-223/Y micewere transfected with specific small hairpin RNA (shRNA) for
C/EBPb and DC differentiation was induced in the presence of
GM-CSF. The knockdown efficiency of the shRNA was more
than 50% (Figure S7). Knockdown of C/EBPb reduced the
GM-DCdifferentiation from themiR-223/YBMcells to a compa-
rable level of that from the BM of control mice (Figures 7A–7C).
Furthermore, knockdown of C/EBPb in miR-223/Y moDCs
significantly reduced the production of TNF-a, IL-6, IL-23, and
IL-12 (Figures 7D–7G). Our data therefore demonstrated that
C/EBPb mediated the pro-inflammatory phenotype of miR-223
deficiency and confirmed that C/EBPb was a bona fide direct
target of miR-223.
DISCUSSION
In this study, we provided strong evidence for an important role
of miR-223 in the regulation of the differentiation and functions ofvember 10, 2015 ª2015 The Authors 1155
Figure 7. Knockdown of C/EBPb Reversed
the Phenotype and Functions of miR-
223/Y DCs
(A) BM cells of miR-223+/Y or miR-223/Y mice
were transfected with shRNA for C/EBPb and then
cultured with GM-CSF and IL-4; 5 days later, the
differentiation of GM-DCs was analyzed by flow
cytometry.
(B and C) The percentages (B) and numbers (C) of
GM-DCs generated in (A) are shown.
(D–G) Sorted moDCs were transfected with
siRNAs for C/EBPb and stimulated with LPS. IL-23
(D), IL-12p70 (E), TNF-a (F), and IL-6 (G) in the
supernatant were detected by ELISA. Data are
representative of three independent experiments;
each included triplicate samples. Error bars
represent SEM (*p < 0.05, **p < 0.01, and ***p <
0.001).intestinal macrophages and DCs. The miR-223 deficiency re-
sulted in a decreased number of intestinal CX3CR1hi macro-
phages. Moreover, the macrophages and DCs isolated from
the intestine of miR-223/Y mice displayed a stronger pro-
inflammatory phenotype. Consequently,miR-223/Ymice devel-
oped more severe colitis in the DSS-induced colitis model.
The miRNAs, a group of small RNA molecules, have been
studied extensively in the development and responses of the im-
mune system. Unique miRNA expression profiles have been
described in epithelial cells of patients with active UC, Crohn’s
ileitis, and Crohn’s colitis, as well as in the peripheral blood of pa-
tients with active UC and CD (Runtsch et al., 2014). However, the
molecular mechanisms underlying the function of these miRNAs1156 Cell Reports 13, 1149–1160, November 10, 2015 ª2015 The Authorsin the disease development were not
clearly understood; particularly, the roles
of these miRNAs in the regulation of
differentiation and functions of intestinal
DCs and macrophages have not been
carefully studied. Given the importance
of intestinal DCs and macrophages in
the maintenance of gut homeostasis,
investigation of the roles of miRNAs in
modulating the differentiation and func-
tions of these immune cells should
provide crucial information for a better
understanding of the molecular and
cellular bases for the development of
intestinal inflammatory diseases, such
as IBD.
By monitoring the changes of miRNAs
in macrophages and DCs during activa-
tion, we found that the myeloid-specific
miR-223 decreased continuously. In
addition to miR-223, the expression of
miR-29, which could be upregulated in
moDCs in response to NOD2 signals
and negatively regulated DSS-induced
colitis by targeting IL-12p40 directly and
IL-23p19 indirectly (Brain et al., 2013),
was decreased in macrophages andDCs in our study. Moreover, miR-155 (Singh et al., 2014), miR-
21 (Shi et al., 2013), and miR-146a (Nata et al., 2013) also have
been reported to play important roles in DSS-induced colitis,
suggesting the combined effects of these miRNAs on the func-
tion of DC and macrophage in colitis.
Recent studies have proposed that intestinal CX3CR1hi
macrophages could exert an anti-inflammatory effect on
colitis, and specific ablation of CX3CR1hi macrophages in
CX3CR1gfp/gfp mice exacerbated disease during acute intestinal
inflammation (Medina-Contreras et al., 2011). In line with this
finding, transfer of WT CX3CR1hi macrophages into myeloid-
specific Stat3-deficient mice had been shown to prevent the
development of colitis (Kayama et al., 2012). By using the
CX3CR1-cremice, Zigmond et al. (2014) found that mice with IL-
10R-specific deficiency in intestinal macrophages developed
colitis spontaneously, highlighting IL-10 as a critical homeostatic
macrophage-conditioning agent in the colon and defining intes-
tinal CX3CR1hi macrophages as a decisive factor that deter-
mines gut health or inflammation. Therefore, maintaining the
number and tolerant state of CX3CR1hi macrophages are partic-
ularly important for gut homeostasis. Our study demonstrated
that miR-223 deficiency led to a significant reduction in the num-
ber of CX3CR1hi macrophages in the intestine. Furthermore, we
found that miR-223 deficiency turned the remaining CX3CR1hi
macrophages to a more pro-inflammatory phenotype. There-
fore, the combined effects of miR-223 on the differentiation
and function of CX3CR1hi macrophages may be one of the
important contributing factors for the aggravated colitis in miR-
223/Y mice.
In steady state, Ly6C+ monocytes give rise to resident non-in-
flammatory CX3CR1hi macrophages; however, when recruited
to inflamed tissues they acquire a distinct fate. Under inflam-
matory conditions, Ly6C+ monocytes could differentiate into
CX3CR1int macrophages in the colon of a colitis model (Zigmond
et al., 2012; Rivollier et al., 2012). Notably, although some studies
suggested that these CX3CR1int macrophages were heteroge-
neous and contained a yet-to-be-defined population of cells,
they exhibited a DC-like phenotype, including higher expression
of CD11c, lower expression of CD64, as well as expression of the
DC marker Zbtb46 (Zigmond et al., 2012; Rivollier et al., 2012;
Bain et al., 2013; Meredith et al., 2012; Satpathy et al., 2012).
Within the small intestine, it has been established that CX3CR1int
cells and the resident CX3CR1hi macrophages were both Ly6C+
monocyte derived (Rivollier et al., 2012); but, functionally, the
CX3CR1int cells were considered to be pro-inflammatory cells
and conditional depletion of CCR2-expressing CX3CR1int cells
has been found to ameliorate DSS-induced colitis (Zigmond
et al., 2012). In this study, we demonstrated that miR-223 dele-
tion significantly promoted the differentiation and activation of
moDCs, which were similar to the reported CX3CR1int cells in
the expression of CD11c and intermediate level of CX3CR1.
The enhanced differentiation of monocytes to moDCs together
with the overactivation of moDCs in miR-223/Y mice exerted
additional effects on the exacerbation of colitis.
According to the DAI score, we noticed that, althoughmiR-223
deficiency did not lead to spontaneous colitis, miR-223-deficient
mice showed a more severe colitis at the early stage of the DSS
treatment. It has been reported that CX3CR1hi macrophages are
located mainly below the intestinal epithelial cells and assist in
the support of the integrity of the intestinal barrier. The reduction
in the number of CX3CR1hi macrophages also may result in
aggravated epithelial cell injury and increased susceptibility to
acute enteritis.
It has been reported that miR-223 is involved in regulating the
differentiation of myeloid cells (Sugatani and Hruska, 2007;
Johnnidis et al., 2008; Fazi et al., 2005; Li et al., 2010; Felli
et al., 2009). Different targets of miR-223 have been identified,
including Mef2c, IKKa, NFI-A, LMO2, E2F1, C/ebpb, and Rhob
(Johnnidis et al., 2008; Fazi et al., 2005; Li et al., 2010; Felli
et al., 2009; Pulikkan et al., 2010; Sun et al., 2010a, 2010b).
Among them, C/EBPb is the only one with known roles in bothCell Rephematopoietic differentiation and inflammatory responses. It
has been shown that C/EBPb was required for emergency gran-
ulopoiesis, facilitating both differentiation and proliferation of
granulocyte precursors (Hirai et al., 2006). C/EBPb, but not
other C/EBP family members, could be induced by GM-CSF,
and GM-CSF-induced proliferation of myeloid cells is impaired
in C/ebpb/ mice (Hirai et al., 2006). Moreover, C/EBPb has
been demonstrated positively regulating the expression of
different pro-inflammatory cytokines, including TNF-a, IL-6,
and IL-12 (Screpanti et al., 1995; Gorgoni et al., 2002; Yan
et al., 2012). In this study, we demonstrated that miR-223 inter-
acted directly with the 30UTR of C/EBPb and the expression of
C/EBPb increased in the miR-223-deficient macrophages and
DCs at the protein level. Moreover, knockdown of C/EBPb in
miR-223-deficient BMmyeloid precursors andmonocytes allevi-
ated the effects of miR-223 deficiency on the differentiation and
pro-inflammatory cytokine production of the macrophages and
DCs derived from these precursors, indicating that C/EBPb
was a bona fide direct target of miR-223, and miR-223 regulated
the differentiation and functions of macrophages and DCs by
directly modulating the expression of C/EBPb.
Besides the function in hematopoiesis, miR-223 has been
considered as an important player in cancer and rheumatoid
arthritis (Wong et al., 2008; Stamatopoulos et al., 2009; Fulci
et al., 2010). In this study, we identified its role in regulating the
differentiation and pro-inflammatory cytokine production of in-
testinal macrophages and DCs. The pro-inflammatory cytokines
including TNF-a, IL-12, and IL-23 were known to drive intestinal
inflammation. Specific blocking reagents of these cytokines
have been developed to treat certain types of IBD (Neurath,
2014). As the major cell types producing these cytokines, a tight
regulation of differentiation and functions of the intestinal macro-
phages and DCs is crucial to avoid excessive responses and to
maintain the homeostasis of the gut. Our study demonstrated
that miR-223 is an important player in maintaining homeostasis
of the intestinal environment. It may serve as a potential target
for the treatment of IBD.
EXPERIMENTAL PROCEDURES
Mice
CD45.1+miR-223/Y mice and CD45.1+CX3CR1gfp/gfp mice (6–8 weeks old)
were purchased from the Jackson Laboratory. CD45.1+miR-223/Y mice
were crossed to CD45.1+CX3CR1gfp/gfp mice to obtain CD45.1+miR-223/Y
CX3CR1gfp/+ mice. All mice were maintained under specific-pathogen-free
conditions in the animal facility of Tsinghua University, and they were used
in accordance with governmental and institutional guidelines for animal
welfare.
Plasmid Construction
The pMXs-DsRed Express was a gift from Shinya Yamanaka (Addgene
plasmid 22724) (Hong et al., 2009). The fragment of Cebp/b 30UTR was cloned
into the 30 end of DsRed. The mutant fragment of Cebp/b 30UTR was cloned
by using KOD-Plus (Toyobo). For shRNA construction, target sequence
50-CACCCTGCGGAACTTGTTCAA-30 in the coding region of mouse C/ebpb
was used to design shRNA and cloned into a lentivirus plasmid pLVX-shRNA2
(Clontech Laboratories).
DSS-Induced Colitis
Mice were provided with 5% or 3% (w/v) DSS dissolved in the drinking water
for 5 days. Daily clinical assessment of DSS-treated animals includedorts 13, 1149–1160, November 10, 2015 ª2015 The Authors 1157
measurement of a validated clinical DAI ranging from 0 to 12, which was calcu-
lated using the following parameters: stool consistency, presence or absence
of fecal blood, and weight loss. Mice were killed at day 5 and colons were as-
sessed for histology.
T Cell Transfer-Induced Colitis Model
Naive CD4+CD25CD45RBhi T cells were isolated from B6 WT mice and were
sorted via fluorescence-activated cell sorting (FACS). Sex-matched B6
Rag1/ recipients were intraperitoneally (i.p.) injected with 4 3 105 cells,
and the development of intestinal inflammation was monitored. Mice were
killed >6 weeks after cell transfer and tissues were collected for cell population
or histological analysis. The moDCs of WT and miR-223/Y mice were gener-
ated in culture with GM-CSF and IL-4, then purified by FACS. The moDCs (33
106) of WT and miR-223/Y mice were i.p. injected into B6 Rag1/ mice that
had received CD4+CD45RBhi T cells 2 weeks earlier.
Then, 10 days post-DC transfer, intestinal tissues were collected for histo-
logic analysis. Mice were killed when symptoms of clinical disease (significant
weight loss or diarrhea) became apparent in control groups. Samples of distal,
mid-, and proximal colon were immediately fixed in buffered 10% formalin.
Paraffin-embedded 5-mm sections were stained with H&E and inflammation
was assessed. Each sample was graded semiquantitatively from 0 to 3 for
the four following criteria: (1) degree of epithelial hyperplasia and goblet cell
depletion; (2) leukocyte infiltration in the lamina propria; (3) area of tissue
affected; and (4) the presence ofmarkers of severe inflammation, such as crypt
abscesses, submucosal inflammation, and ulcers. Scores for each criterion
were added to give an overall inflammation score for each sample of 0–12.
Construction of BM Chimeras
C57BL/6J recipients were lethally irradiated by X-ray (5 Gy3 2), and then intra-
venously transferred with a combination of 2 3 106 BM leukocytes from
C57BL/6J mice and indicated donor BM cells mixed at the ratio of 1:1. Chi-
meras were used for experiments 4 weeks after the initial reconstitution.
ELISA
The colons of DSS-treated mice were flushed with Hank’s balanced salt solu-
tion (HBSS) and opened along a longitudinal axis. The 3-mm punch biopsies
were obtained from the distal colon and incubated for 48 hr in 200 ml RPMI sup-
plemented with 10% fetal calf serum (FCS) and antibiotics. Supernatants were
collected and the cytokines IL-6, TNF-a, and IL-1b were assessed with the
mouse ELISA Ready-SET-Go! kits (eBioscience). IL-23 was assessed with
the mouse ELISA kit from R&D Systems.
Cell Differentiation, Stimulation, and Transfection
To obtain GM-DCs or moDCs, total BM cells or Ly6C+ monocytes separated
from BM were cultured with 100 ng/ml GM-CSF and 100 ng/ml IL-4 (Pepro-
Tech), respectively. Then, 6 days later, immature moDCs were harvested
and stimulated with 1 mg/ml LPS (InvivoGen) for 24 hr. Supernatants were
collected. To obtain BM-derived macrophages, Ly6C+ monocytes were
cultured with 100 ng/ml M-CSF (PeproTech) for 6 days.
For BM cell transfection, total BM cells were pre-stimulated with GM-CSF
for 24 hr and then incubated with lentivirus for another 24 hr. For moDC or
macrophage activation, sorted immature moDCs or macrophages were trans-
fected with 100 nM small interfering RNA (siRNA) (Santa Cruz Biotechnology)
specific for C/EBPb or control siRNA using Lipofectamine RNAiMAX (Invitro-
gen), and then they were stimulated with 1 mg/ml LPS 2 days after transfection.
Quantitative Real-Time RT-PCR
Total RNA was extracted by Trizol reagent (Invitrogen). Reverse transcription
of miRNA to cDNA was achieved with miRNA-specific primers (Applied Bio-
systems) prior to qPCR (TaqMan; Applied Biosystems). Noncoding small
RNA control sno202 (Applied Biosystems) served as an endogenous reference
gene, with changes in expression calculated by the change-in-threshold
(DDCT) method. For mRNA, cDNA was prepared by reverse transcription (Pri-
meScript RT Reagent kit, Takara) and amplified by real-time qPCR with the
primers shown in Table S1. Equal amounts of cDNA were used for the subse-
quent qPCR performed with the SYBR PrimeScript RT-PCR kit (Takara).
Amplification was performed in an ABI PRISM 7900 Real Time PCR System1158 Cell Reports 13, 1149–1160, November 10, 2015 ª2015 The Au(Applied Biosystems). The amplification efficiency of these genes was the
same as that for b-actin, as indicated by the standard curves for amplification,
allowing us to use the following formula: fold difference = 2(DCtA  DCtB), where
Ct is the cycle threshold.
Cell Isolation, Flow Cytometry Analysis, and Cell Sorting
Small intestines were removed and carefully cleaned of their mesentery and
Peyer’s patches were excised. Then, intestines were opened longitudinally,
washed of fecal contents, cut into pieces that were 0.5 cm in length, and
subjected to two sequential 20-min incubations in HBSS with 5% FCS and
2 mM EDTA at 37C and agitation to remove epithelial cells. After each incu-
bation step, media containing epithelial cells and debris were discarded. The
remaining tissue was minced and incubated for 40 min in RPMI with 5%
FCS, 10 U/ml collagenase CLSPA (Worthington Biochemical), and 40 U/ml
DNase I (Roche) at 37C in agitation. Cell suspensions were collected
and passed through a 100-mm strainer and pelleted by centrifugation at
1,700 rpm.
For spleen DC separation, the cDCs and plasmacytoid DCs (pDCs) were en-
riched from spleen by digesting the tissue fragments with collagenase III and
DNase I, followed by light-density separation and then immune-magnetic
bead depletion using the procedure described elsewhere (Carotta et al.,
2010). For BM progenitor enrichment, red cells were removed, followed by
gradient-density separation and then immune-magnetic bead depletion using
the procedure described elsewhere (Sathe et al., 2014).
Antibodies used for colonic staining included the following: fluorochrome
or biotin-conjugated monoclonal antibodies (mAbs) specific to mouse
CD115 (clone AFS98); CD45.2 (clone 104); CD45 (clone 30-F11); CD45.1
(clone A20); F4/80 (clone BM8); Ly6G (clone 1A8); CD11c (clone N418);
CD103 (clone 2E7); CD34 (clone RAM34); CD135 (clone A2F10); CD117
(clone ACK2); Ly6A/E (clone D7); CD127 (clone A7R34); MHCII (clone M5/
114.15.2); Ly6C (clone H1.4); Siglec-H (clone eBio440c); CD8a (clone
53-6.7); CD172a (clone P84); CD11b (clone M1/70); corresponding isotype
controls; and the secondary reagent PE-Cy7, APC, BV605, BV421, PE,
fluorescein isothiocyanate (FITC)-conjugated streptavidin antibodies. All
these antibodies were purchased either from BD Biosciences or eBioscience.
Cells were analyzed with a LSRII flowcytometer (Becton Dickinson) or sorted
with a FACSAria III machine (BD). Flow cytometry analysis was done with the
FlowJo software.
Immunoblots
CX3CR1hi macrophages (5 3 105) or moDCs (1 3 106) were lysed in radioim-
mune precipitation assay lysis and extraction buffer (Thermo Fisher Scientific).
Individual cell lysates (5 mg/lane) were separated by 10% SDS-PAGE and
transferred to an Immobilon-P polyvinylidene difluoride membrane (Millipore).
After being blocked with SuperBlock T20 PBS blocking buffer (Thermo Fisher
Scientific), the membranes were incubated with rabbit monoclonal antibodies
against C/EBPb (1:1,000, C-19, Santa Cruz) and b-actin (1:2,000, 4967, Cell
Signaling Technology). The intensities of bands were analyzed by using Image
J software.
Statistical Analysis
Data were analyzed by ANOVA followed by Bonferroni multiple comparison
test or by unpaired, two-tailed t test with GraphPad Prism 5. Data are pre-
sented as mean (±SEM); p < 0.05 was considered statistically significant.
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